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Abstract
Degeneration of intracranial aneurysm wall is under active research and recent studies indicate an increased risk of rupture of
intracranial aneurysm among patients with periodontal diseases. In addition, oral bacterial DNA has been identified from wall
samples of ruptured and unruptured aneurysms. These novel findings led us to evaluate if oral diseases could predispose to
pathological changes seen on intracranial aneurysmwalls eventually leading to subarachnoid hemorrhage. The aim of this review
is to consider mechanisms on the relationship between periodontitis and aneurysm rupture, focusing on recent evidence.
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Introduction
Recently, our group found the association with periodontitis,
formation of intracranial aneurysms (IA), and the risk of an-
eurysmal subarachnoid hemorrhage (aSAH) [25]. Together
with the prior reports that DNA of oral bacteria is found in
the wall of many ruptured intracranial aneurysms [64, 65],
these results raised the intriguing question whether periodon-
titis and oral bacteria participate to the formation of IAs and to
their progression towards rupture. We review the current re-
search about the association of oral infections with aneurysms
and other vascular diseases, and discuss the potential mecha-
nisms by which oral infections may modulate, contribute to,
or even cause the degenerative remodeling of the aneurysm
wall and as such predispose to the risk of aneurysmal sub-
arachnoid hemorrhage.
Intracranial aneurysms as a clinical challenge—need
for identification of rupture-prone aneurysms
Intracranial aneurysms (IA) are pathological dilatations of ce-
rebral arteries, most often saccular in shape and frequently
found in proximal cerebral artery bifurcations [30].
Aneurysms are relatively common with a prevalence of 2–
3% in the general population [70, 91].
Although unruptured IAs are common, intracranial hemor-
rhage caused by IA rupture is a quite rare event affecting 10–11/
100000 population per year inWestern populations [32]. In fact,
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based on epidemiological data, it seems that only approximately
1%of IAs rupture per year [70] andmany of them actually never
rupture during the lifetime of the person carrying them [41].
However, because of the serious consequences that IA rupture
and subsequent intracranial hemorrhage have (40% mortality
andmost of the survivors being left with significant neurological
impairment [54, 78]), many of the diagnosed unruptured IAs are
treated to prevent rupture. Preventive treatment is done by
endovascular embolization of aneurysm sack or by microsurgi-
cal ligation of the aneurysm neck, both of which exclude the
aneurysm from systemic circulation. Both of the current treat-
ment options are associated with significant risk of serious neu-
rological complications (5–7%), including mortality (1–2%)
[43, 53]. Therefore, it is paramount to focus intervention only
to those IAs at risk of rupture. This remains a challenge.
The discrepancy between the relatively high prevalence of
unruptured IAs and the low incidence of IA rupture, together
with the observation that only 1/3 of unruptured IAs ruptured
during a life-long follow-up [41], strongly suggests that IA
formation and IA rupture are two separate phenomena with
different pathological background. Moreover, these observa-
tions suggest that while some IAwalls are able to adapt to the
mechanical load imposed on them, in others degenerative re-
modeling makes the IAs rupture-prone. This in turn implies
that by pharmacological manipulation of the adaptive or de-
generative remodeling of the IA wall, it might be possible to
keep the formed unruptured IAs stable and prevent rupture. To
achieve this, the pathophysiological mechanisms guiding IA
growth and rupture, i.e., adaptive and degenerative wall re-
modeling, need to be understood. Moreover, biomarkers for
an IAwall capable of adaptive remodeling are needed to iden-
tify those IAs that can be stabilized with drug therapy.
Intracranial aneurysms show chronic inflammation
that is associated with wall degeneration and rupture
Since human tissue samples from the site of IA initiation are
inherently difficult to obtain, most of our knowledge of the
pathophysiological mechanisms leading to IA formation is de-
rived from animal models of induced IA formation [1, 27, 34,
39]. Current understanding is that IAs form as the end result of
flow-driven inflammatory cell-mediated cerebral artery wall re-
modeling at the sites where high flow causes high wall shear
stress (WSS) [22, 75](Fig. 1). However, not all cerebral artery
bifurcations exposed to high WSS develop IAs, suggesting that
additional factors are needed [22]. A common feature to IA
initiation is the disruption of internal elastic lamina (IEL) [27,
39], resulting in distension of the vessel wall to the extent that
collagen fibers allow [22]. In a mouse model of induced IA
formation, IEL disruption is related to flow-induced macrophage
infiltration [22, 34]. In humans, however, systemic elastase ac-
tivity may play a significant role since increased serum elastase
concentrations associate with IAs [10], although the source is
unknown. Potential sources for circulating elastase are macro-
phages or neutrophils [13, 68]. Given that chewing or brushing
teeth predisposes to transient bacteremia, especially in patients
with gingivitis or periodontitis [16, 28, 49, 84], activation of
circulating neutrophils as a response to transient bacteremia of
periodontal pathogens with subsequent formation of neutrophil
extracellular traps (NETs) and elastase release [13] could lead to
wall degeneration (Fig. 2)—thus explaining why IA form for
some but not all persons under high flow and shear stress towards
bifurcations of cerebral arteries [75].
In humans, increased infiltration of leukocytes, mainly mac-
rophages and to some extent T cells, is observed in ruptured IA
walls compared with unruptured IAwalls [18, 37, 55]. The ob-
servation that inflammatory cell infiltration is present in
unruptured IAs as well as in ruptured IAs operated early after
rupture, combined with the observation that this inflammatory
cell infiltration does not associate with time from rupture [18],
strongly implies that the inflammatory cell infiltration is present
before rupture. Thus, inflammatory cell infiltration associates
with wall degeneration in both unruptured and ruptured IAwalls
[56, 57]. In animal models of induced IA formation, blocking
macrophage infiltration or activation inhibits the formation,
growth, and rupture of the IAs [2, 3, 36, 74].





Larger aneurysm Wall tension increases
Thicker aneurysm wall Wall tension decreases
Wall calcificaon









causes endothelial dysfunction in
arterial wall, which predisposes
arterial wall to high flow
condition. Simultaneously
macrophage infiltration is
observed in the arterial wall and
IA formation accelerates
240 Neurosurg Rev (2021) 44:239–247
Inflammatory response mediated especially by macro-
phages is an essential part of the flow-induced vessel remod-
eling that leads to aneurysm initiation and growth [22].
However, in the human IA wall also a humoral immune re-
sponse and activation of the complement system are observed
and associating with wall degeneration in unruptured IAwalls
as well as with rupture [86, 87]. This strongly implies that the
chronic inflammation seen in human IAwalls is not just relat-
ed to flow-induced remodeling, especially since there is very
high variation in the inflammation degree among IAs [18, 55,
86] despite the fact that all are exposed to non-physiological
flow. The cause of this inflammation in the IAwall is unclear.
Potential triggers of inflammation include circulating lipids
[20, 88] and periodontal and cariogenic bacteria [31, 64, 65].
The highly prevalent oral infections, dental caries
and periodontitis, and their systemic effects
Dental caries and periodontitis are both highly prevalent oral
diseases worldwide despite the modern dental therapy and
accumulating knowledge of oral diseases. Caries is an infec-
tive disease of hard tissues of the tooth, and the prevalence of
untreated caries is one-third of the global population as well as
in Europe [17] In the USA and Asia pacific, the prevalence
varies between 22 and 25% [17]. Another common oral dis-
ease, periodontitis, is also to a large extent preventable inflam-
matory disease and highly underdiagnosed. Its severe form
affects about 10% of the global population, and 7% in Asia
pacific area [17]. In the USA, the prevalence of mild to mod-
erate and severe periodontitis is reported to be 46% and 9% of
adults, respectively [14]. In Europe, corresponding prevalence
is 40–60% and 10–20% [17], respectively.
The microbial load on tooth surface, dental plaque, composed
of hundreds of microbial species [59]. Periodontal pathogenesis
initiates by microbial accumulation on the tooth surface resulting
a reversible gingival inflammation known as gingivitis [77, 83],
which may progress to periodontitis among susceptible individ-
uals when the normally dominating beneficial species become
lessened and replaced by pathogenic species [40]. Therefore,
endured microbial burden, in form of dental plaque or calculus,
leads to a chronic inflammatory disease—periodontitis. Without
interventional therapy, periodontitis leads to breakdown of both
soft and hard tissue mainly via inflammatory host response [11]
causing loss of tooth attachment and eventually loss of alveolar
bone in the jaws. Periodontitis not only degenerates tooth sur-
rounding structures but affects the inflammatory system [35, 51,
52, 60, 62] and systemic health [12, 25, 38, 45, 46, 63, 79].
Periodontitis is associated with the risk of several diseases.
For example, in rheumatoid arthritis, Porphyromonas gingivalis
(PG), one of the most common periodontal pathogens, seems to
be potential generator of autoantibodies [50]. Periodontitis has
also been associated with atherosclerosis, stroke [38, 46, 63], and
abdominal aortic aneurysms (AAA) [12, 45, 79]. Very recently,
our group showed that periodontitis or gingivitis associate also
with aSAH and IA formation [25]. In addition to this, another
recent study reported an association between aSAH and being a
carriage of specific strains of Streptococcus mutans, a significant
contributor to tooth decay [31]. These clinical studies suggest
that oral infections and exposure to oral pathogens associate with
risk of IA formation and aSAH.
Potential role of periodontal pathogens
in the pathobiology of the intracranial aneurysm
In addition to the clinical association of periodontitis with IA
formation and aSAH suggesting a potential causative association,
a recent experimental study has reported that temporary ablation
of the gut microbiome prevents IA formation through indirect
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modulation of the inflammatory remodeling in the cerebral arter-
ies [21, 73]. This experimental study highlights the thus far un-
noticed importance of microbial exposure in the pathogenesis of
IAs.
While it has been long known that septic, bacterial emboli
ending up in cerebral arteries may cause formation of so-
called mycotic aneurysms through focal inflammation of the
artery wall, most saccular IAs have been considered as being
aseptic. However, a landmark study screening human IAwall
tissue samples for the presence of any bacterial DNA demon-
strated DNA of oral pathogens in up to 50% of ruptured IA
walls [64, 65]. The fact that the remaining 50% were negative
for any bacterial DNA demonstrates that IAs can formwithout
direct bacterial involvement. The combination of having an
epidemiological association between periodontal infection
and IA formation and rupture [25, 66], experimental proof that
microbiome exposure modulates IA formation [21, 73], and
that even presence of oral pathogen remnants is found inmany
IAwalls [64, 65] justifies the hypothesis that periodontal path-
ogens contribute to the risk of IA formation and rupture
through indirect or direct modulation of the inflammatory re-
modeling in the cerebral artery and IAwall.
Potential mechanisms through which oral pathogens
can affect inflammatory remodeling in the IA wall
We will focus on those periodontal pathogens that have been
identified inwalls of ruptured intracranial aneurysms by Pyysalo
et al. [64, 65] and discuss through their known role in other
vascular diseases their potential contribution to IA pathogenesis.
The importance of macrophage infiltration for the inflamma-
tory remodeling leading to IA formation has been demonstrated
by several studies [3, 22, 36, 74, 80], including the landmark
experimental studies by Kanematsu et al., Shimada et al., and
Aoki et al. [3, 36, 74]. P. gingivalis can stay viable in human
macrophages and dendritic cells [7, 76, 92] and thus possibly
disseminate to IAwall via macrophage infiltration. P. gingivalis
seems to be capable of modifying the function of dendritic cells,
for example, the secretion of collagen degrading MMP-9 is pro-
moted in dendritic cells that are infected with P. gingivalis [7]. In
addition, presence of P. gingivalis and Fusobacterium nucleatum
(FN) DNA has shown to induce proinflammatory cytokine pro-
duction in macrophages [71, 72]. Thus P. gingivalis infection of
the macrophages that infiltrate the cerebral arteries would likely
lead to excessive collagen degradation and local inflammation
response, predisposing to IA formation.
Another mechanism through which circulating components
of oral bacteria could enhance or amplify the inflammatory
remodeling of the cerebral artery wall is through activation of
toll-like receptors by LPS, e.g., from P. gingivalis in luminal
thrombus [12](Fig. 3). Toll-like receptors are expressed in an-
eurysm walls [64] and their stimulation triggers activation of
the transcription factor NFkB [3], a main mediator of the
inflammatory remodeling leading to IA formation [3]. As a
result, having oral bacteria-derived components in the circula-
tion would promote inflammatory vessel remodeling triggered
by, e.g., high flow, and thus predispose to IA formation.
Viable periodontal bacteria, namely P. gingivalis,
Aggregatibacter actinomycetemcomitans (AA), and Treponema
denticola (TD), have been found in human atheromas [8, 44, 67]
(Fig. 4). In vitro and in vivo studies havewell established that it is
biologically plausible that periodontitis accelerates atherosclero-
sis [6, 33, 48, 69]. Recent mechanistic study using ApoEnull
mouse model revealed an ability of P. gingivalis to actively in-
vade luminal side of aortic wall, retaining its vitality and leading
to greater aortic plaque area [47, 90]. In another mechanistic
study using a pig model, circulating P. gingivalis promoted ath-
erosclerosis not only in hypercholesterolemic pigs but also
normocholesterolemic ones [6]. These findings suggest that the
active invasion of periodontal pathogens in the artery wall with
or without presence of cholesterol can be a potential trigger of
atherosclerotic activity. Nearly all intracranial aneurysms feature
at least minor atherosclerotic changes and advanced atheroscle-
rotic changes are seen in large numbers [20, 42]. Of note is that
the accumulation of lipid and oxidized low-density lipoprotein
(oxLDL) was found to associate with IAwall degeneration, loss
of mural cells, and also IA rupture, despite normal lipid levels
[20]. Interestingly, not only has P. gingivalis been shown to ac-
celerate atherosclerosis [6, 90] but immunization against it has
been shown to reduce atherosclerotic changes [24, 89]. Thus,
accumulation of oxidized lipids to the IA wall and subsequent
atherosclerotic remodelingmight be altered indirectly by system-
ic immunization induced by local periodontitis. It seems possible
that the presence of P. gingivalis in the IA wall or immune re-
sponse induced by P. gingivalis elsewhere in the bodymaymod-
ulate directly or indirectly the progression of atherosclerotic
changes and lipid-induced inflammation in the IAwall.
Periodontitis is common also among patients with abdominal
aortic aneurysms (AAA) and periodontal bacterial DNA have
been identified in AAAwall structure as well as in the thrombus
lining the AAA inner wall [12, 45]. Presence of periodontal
bacteria promotes AAA growth, i.e., enlargement of luminal
diameter [4, 12], and thus could predispose AAA to rupture.
P. gingivalis appears to promote AAApathogenesis bymaintain-
ing inflammation and increasing oxidative stress in theAAAwall
via adhesion to the intraluminal thrombus [12]. P. gingivalis has
an affinity for thrombus and can passively accumulate to sites of
thrombosis if it is present in the bloodstream [12]. In the throm-
bus, P. gingivalis is capable of inducing the formation of
neutrophil-derived extracellular traps (NETs), which increases
further the accumulation of neutrophils to the thrombus [12].
Fontaine et al. have shown that the neutrophils in the intraluminal
thrombus are amajor source of proteolytic activity as they release
matrix metalloproteinases MMP-8, MMP-9, and elastase [15,
29]. Furthermore, the neutrophils attracted to luminal thrombus
produce proteases and cytotoxic enzymes such as
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myeloperoxidase (MPO) [15, 29], which generates, e.g., hydro-
gen peroxide and hypoclorous acid intended to kill bacteria and
leading to very high oxidative stress locally [26]. In addition to
increasing the local recruitment of neutrophils, P. gingivalis can
also activate the neutrophils in the thrombus, thus accelerating
the neutrophil-derived proteolytic and cytotoxic injury [12](Fig.
2). This cytotoxic injury is in part mediated byMPO. In summa-
ry, presence of P. gingivalis in the intraluminal thrombus or ad-
jacent AAA wall can trigger or enhance the activation and re-
cruitment of neutrophils, leading to excessive proteolytic and
cytotoxic injury to the vessel wall. Similarly to AAAs, neutro-


































Fig. 4 Periodontal bacteria have ability to dysregulate complement
activity with their proteinase production (Porphyromonas gingivalis
PG, Prevotella intermedia PI, and Tannerella forsythia TF) or directly
binding complement factor C4bp and factor H (Porphyromonas
gingivalis PG, Prevotella intermedia PI, Treponema denticola TD, and
Aggregatibacter actinomycetemcomitans AAA). These bacteria
simultaneously accelerate complement activity yet evade complement-
mediated killing is unique and could partially explain inflammation in
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Fig. 3 High flow conditions stretch the vessel wall and induce monocyte
chemoattractant protein 1 (MCP-1) in vascular smooth muscle cells
(VSMC) attracting invading macrophages to vessel wall. Similar MCP-
1 production is caused by lipopolysaccharide (LPS) production of peri-
odontal bacteria via activating nuclear factor kB (NFkB) -signaling via
toll-like receptors. These mechanisms lead to cyclo-oxygenase 2-prosta-
glandin E2-NFkB-cyclo-oxygenase 2 (COX2-PGE2-NFkB-COX2)-am-
plifying loop in IAwall and lead to proliferation of smooth muscle cells
expanding the IA
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[18, 19, 56]. Luminal thrombus is common in IAs [18], as is
periodontitis in IA patients [25, 66] suggesting that P. gingivalis
might accelerate neutrophil-driven thrombus-derived proteolytic
and cytotoxic injury in the IA wall similarly to the AAAwalls.
Indeed, MPO expression has been demonstrated in human IA
walls [23, 56] and locally higher MPO concentrations have been
observed in serum from aneurysm sac than to femoral artery
blood [9].
Besides the infiltration of inflammatory cells such as macro-
phages and neutrophils, activation of the complement system is
involved in IA wall degeneration and rupture [86, 87]. It has
been shown earlier that periodontal bacteria can dysregulate
complement activity in vitro by binding to or degenerating
complement factors [35, 51, 52, 60, 62]. Of periodontal patho-
gens, specific strains of Prevotella intermedia (PI) and
P. gingivalis participate in complement activation by binding
factor H [51] and C4bp respectively [61]. Treponema denticola
(TD) and A. actinomycetemcomitans, common periodontal
pathogens, have ability to bind factor H [5, 52]. These bacteria
do not only dysregulate complement activity but also evade
complement-mediated killing in response of binding factor H
[51, 52]. It is noteworthy that DNA of both P. intermedia and
T. denticola have been identified in some of ruptured IAs [64,
65]. Interestingly, P. gingivalis, P. intermedia, and Tannerella
forsythia (TF) are capable of evading complement-mediated
killing by altering complement activity and degenerating com-
plement factors via their bacterial proteases, while protecting
other bystander-bacteria [35, 60, 62]. This ability of periodontal
bacteria to activate complement while evading complement-
mediated killing may in part explain the complement activation
seen in the IAwall in association with IAwall degeneration.
In addition to the mechanisms described above, periodontal
bacteria may also trigger IA wall degeneration via endothelial
dysfunction, which seems to be one of the key events that
triggers the lipid accumulation, luminal thrombosis, and inflam-
mation that associate with the IA wall degeneration [19]. A
recent meta-analysis concluded that periodontal bacteria predis-
pose to endothelial dysfunction [58]. Moreover, endothelial
dysfunction improves with periodontal treatment [58, 85].
Endothelial dysfunction can be at least in part caused by bacte-
rial burden of periodontitis and furthermore, endothelial dys-
function could explain why periodontal bacteria are often found
in the sites of vascular diseases, e.g., IA walls and atheromas.
Interestingly, periodontitis patients also have higher concentra-
tion of circulating oxidized LDL particles in the blood [81, 82],
another mechanism more through which periodontitis can ac-
celerate local atherosclerotic remodeling in the IAwall.
Conclusion
Although the association of aneurysm rupture with chronic
inflammation of the aneurysm wall is well established, the
triggers for this inflammatory reaction are incompletely un-
derstood. The recent finding that periodontitis or gingivitis
associates with increased risk of aSAH together with DNA
of oral bacteria found in the walls of many IAs raises the
hypothesis that oral infections are related to the inflammation
of the IA wall. In this review, we presented several mecha-
nisms by which periodontitis and periodontal pathogens can
contribute to the degenerative remodeling of the IA wall.
These mechanisms merit further investigation and may reveal
a previously unknown and treatable risk factor for the deadly
aneurysmal subarachnoid hemorrhage.
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